Par Drugs and Chemicals Limited — Important, 14-05-2026: Updates
14-05-2026 · 06:32 pm
Company approved financial results for the quarter and year with an unmodified auditor's opinion, despite regulatory restraint on a planned business restructuring. The Board approved new investments up to ₹90 Cr and renewed a banking facility of ₹1.61 Cr.
No comments yet. Be the first to comment!
